Trends in List and Net Prices of Self-administered Systemic Psoriasis Therapies Manufactured by US-Based Pharmaceutical Companies.
Where this comes from
- Record sourced from PubMed, PMID 32785612.
- Also identified by DOI 10.1001/jamadermatol.2020.2685 and PMC identifier 7557512.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This economic evaluation reviews the trends in list and net price data from SSR Health for the 2007 to 2019 period of self-administered systemic psoriasis medications manufactured in the United States.
Medical subject headings
- Biological Products
- Dermatologic Agents
- Drug Costs
- Drug Industry
- Health Expenditures
- Psoriasis